Quantum-Si Laying off 12 Percent of Workforce
The restructuring, which is intended to decrease costs and streamline the firm, comes as it begins commercialization of its Platinum protein sequencing platform.
Drugs to Treat Smoking Addiction Suggested by Multi-Ancestry Transcriptome-Wide Association Study
The new approach, called TESLA, enables eQTL datasets to be integrated with multi-ancestry GWAS, which the researchers applied to study smoking behaviors.
Guardant Health Nabs FDA Approval for Liquid Biopsy CDx With Menarini Breast Cancer Drug
The firm's liquid biopsy assay Guardant360 CDx can now be used to identify patients eligible for treatment with Menarini's Orserdu in ESR1-mutant breast cancer.
GeneDx to Raise $150M in Public and Direct Stock Offerings
Expected to close Jan. 31, the stock sales are intended to help the firm build up working capital, repay debts, and make strategic investments.
Ravgen NIPT Patents Withstand Illumina Challenge
The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.